This new reference creation is quite unusual; in general, it is reserved for the 20% of medical devices deemed to offer an improvement in the expected service compared to existing solutions.
The new Aqualeg reference and the new price were created after an administrative procedure, tests and clinical studies that lasted more than two years. It is an important recognition and a key step for this Nantes company which aims to extend this standardization to other countries.
By 2018, Aqualeg is aiming at an annual turnover of 2 million euros, with a team of about ten people. Important developments are expected abroad, in Europe in the short term, and then in increased exports.
The start-up company, a member of Atlanpole Biotherapies cluster, is now moving into an industrial phase, both in its production processes and in its commercial tools. They now mainly draw on an IPad application, which allows the practitioners to visualize augmented reality products and realize a 3D scan of their patients directly on their IPad. ”